cbdMD Inc

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded by Caryn Dunayer on March 17, 2015 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading, most highly trusted, and most recognized cannabidiol (CBD) brands, announced today that in conjunction with the Natural Products Association (NPA), with the goal to better clarify the landscape for investors, is launching an invitation only virtual investor conference entitled “Regulatory Roadmap For The CBD Industry”, which will focus on discussing the current regulatory climate

cbdMD and The Natural Products Association Launch “Regulatory Roadmap For The CBD Industry”

CbdMD Inc. (NYSE: YCBD) has signed a multi-year retail distribution agreement with health club chain Life Time Inc.

After Bellator, Barstool And GNC Deals, cbdMD Has 'High Hopes' For Life Time Partnership

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc.

cbdMD Signs Multi-Year, Exclusive Retail Distribution Agreement With Life Time, Inc.

cbdMD Launches Brand’s First National Television Advertising Campaign

LAS VEGAS--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading and most highly trusted and recognized cannabidiol (CBD) brands, is proud to support MMA champion Daniel “DC” Cormier, a premier member of “Team cbdMD”, which is the CBD industry’s premier athletic sponsorship program, as he prepares for the fight of his career.

MMA Champion Daniel Cormier Trusts cbdMD To Prepare for the Fight of His Career

cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q3 2020 Results - Earnings Call Transcript

cbdMD Reports Record Net Sales In Its Third Quarter Fiscal 2020 Results

cbdMD’s Pet Brand, Paw CBD, Sees Sales Increase 64% from March 2020 Quarter to June 2020 Quarter

cbdMD Expands Sponsorship with Professional Golfer Bubba Watson

cbdMD, Inc. To Host Conference Call To Discuss Third Quarter 2020 Results

cbdMD Continues Exclusive CBD Marketing Partnership with Bellator MMA

Without a strong moat, YCBD stock is a risky stock yet it could double if it keeps cutting operating costs while growing revenue.
The post Right Now, cbdMD Stock Is a Speculation That Could Pay off Big appeared first on InvestorPlace.

Right Now, cbdMD Stock Is a Speculation That Could Pay off Big

CbdMD Inc (NYSE: YCBD) was in-line with analyst expectations as the company confirmed April sales remained flat during March.

Analyst Shares Thoughts On cbdMD's Q2 Earnings: 'Sustainable Ongoing Operation'

cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q2 2020 Results - Earnings Call Transcript

CbdMD (YCBD) earnings for the marijuana company's fiscal second quarter of 2020 have YCBD stock heading higher on Monday.

CbdMD Earnings: YCBD Stock Shoots 78% Higher on Q2 Beat

cbdMD's (YCBD) Management on Q1 2020 Results - Earnings Call Transcript

cbdMD, Inc. (YCBD) CEO Martin Sumichrast on Q4 2019 Results - Earnings Call Transcript

News for cbdMD Inc Stock (YCBD)